On January 14, 2019, Trice Medical, Inc. amended the terms and closed the transaction. The company will now receive $42,295,088 in the transaction. The company has received $40,580,088 from 47 investors in the transaction. The company has received $21,314,624 in the second and final tranche of the series C round of funding. The tranche was led by new investors The Charter Group, Ltd. and Municipal Employees' Retirement System of Michigan and involved participation from existing investors Safeguard Scientifics, Inc. (NYSE:SFE), HealthQuest Capital, BioStar Ventures LLC, Smith & Nephew plc (LSE:SN.) and other investors.